Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. |
Relapsing Multiple Sclerosis | Phase3 | Argentina Australia Canada Denmark France Italy Slovakia South Africa Spain Switzerland United States View all |
NCT06846281 |
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. |
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease | Phase3 | Argentina South Korea United States |
NCT06858319 |
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis |
Rheumatoid Arthritis | Phase1 | Argentina Bulgaria China Germany Netherlands Romania Spain View all |
NCT07029555 |
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. |
Chagas Disease | Phase2 | Argentina Brazil Colombia United States View all |
NCT06632600 |
LATAM LOWERS LDL-C |
Hypercholesterolaemia | Phase4 | Argentina Brazil |
NCT06501443 |
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase3 | Argentina Austria Belgium Canada Colombia Czechia France Germany Greece Hungary Malaysia Poland Puerto Rico Romania Spain Turkey (Türkiye) United Kingdom United States View all |
NCT06840392 |
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase3 | Argentina Australia Bulgaria Canada China Colombia Denmark Germany Greece Italy Malaysia Mexico Poland Portugal Slovakia South Africa Spain Switzerland Taiwan United States View all |
NCT06799000 |
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Heterozygous | Phase3 | Argentina Austria Belgium Brazil China Czechia France Germany Greece Hong Kong Hungary Israel Italy Malaysia Netherlands Poland Portugal South Africa Spain Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT06597019 |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Austria Belgium Brazil Bulgaria Chile China Colombia Croatia Denmark Georgia Guatemala Hong Kong India Ireland Israel Italy Jordan Latvia Lebanon Lithuania Malaysia Mexico Netherlands Poland Saudi Arabia Slovakia Spain Switzerland Taiwan Turkey (Türkiye) United Arab Emirates United Kingdom United States View all |
NCT05147220 |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Argentina Austria Bulgaria Colombia Czechia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain Vietnam View all |
NCT05562466 |